Download Bibliography - Rethink Opioids

Why Rethink Opioids?
Bibliography
Brown J, Setnik B, Lee K, et al. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse
in the primary care setting. J Opioid Manag. 2011;7(6):467-483.
Centers for Disease Control and Prevention. Primary Care and Public Health Initiative. Prescription Drug Abuse and Overdose:
Public Health Perspective. October 24, 2012. http://www.cdc.gov/primarycare/materials/opoidabuse/docs/pdaphperspective-508.pdf. Accessed May 20, 2014.
Centers for Disease Control and Prevention. QuickStats: Number of deaths from poisoning, drug poisoning, and drug
poisoning involving opioid analgesics—United States, 1999–2010. MMWR Morb Mortal Wkly Rep. 2013;62(12):234.
Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers and other drugs
among women—United States, 1999-2010. MMWR Morb Mortal Wkly Rep. 2013;62(26):537-542.
Chou R, Fanciullo GJ, Fine PG, et al; American Pain Society–American Academy of Pain Medicine Opioids Guidelines Panel.
Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-130.
Daubresse M, Chang HY, Yu Y, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 20002010. Med Care. 2013;51(10):870-878.
Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic
pain. Pain Med. 2005;6(2):107-112.
Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010.JAMA. 2013;309(7):657-659.
Manchikanti L, Abdi S, Atluri S, et al; American Society of Interventional Pain Physicians. American Society of Interventional
Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2—guidance. Pain
Physician. 2012;15(3 suppl):S67-S116.
Matthias MS, Krebs EE, Collins LA, Bergman AA, Coffing J, Bair MJ. “I'm Not Abusing or Anything”: Patient-physician
communication about opioid treatment in chronic pain. Patient Educ Couns. 2013;93(2):197-202.
Matthias MS, Parpart AL, Nyland KA, et al. The patient-provider relationship in chronic pain care: providers' perspectives. Pain
Med. 2010;11(11):1688-1697.
Passik SD. Issues in long-term opioid therapy: unmet needs, risks, and solutions. Mayo Clin Proc. 2009;84(7):593-601.
Salinas GD, Susalka D, Burton BS, et al. Risk assessment and counseling behaviors of healthcare professionals managing
patients with chronic pain: a national multifaceted assessment of physicians, pharmacists, and their patients. J Opioid Manag.
2012;8(5):273-284.
Substance Abuse and Mental Health Services Administration (SAMHSA).Drug Abuse Warning Network, 2011: National
Estimates of Drug-Related Emergency Department Visits. Rockville, MD: SAMHSA; 2013. HHS Publication No.(SMA) 13-4760,
DAWN Series D-39.
Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Behavioral Health Statistics and Quality.
Treatment Episode Data Set (TEDS).2001–2011.National Admissions to Substance Abuse Treatment Services. Rockville, MD:
SAMHSA Office of Applied Studies; 2013. BHSIS Series S-65, HHS Publication No. (SMA) 13-4772.
US Department of Veterans Affairs, US Department of Defense.VA/DoD Clinical Practice Guideline for Management of Opioid
Therapy for Chronic Pain. Version 2.0. Washington, DC: US Dept of Veteran Affairs, US Dept of Defense; 2010.
http://www.va.gov/PAINMANAGEMENT/docs/CPG_opioidtherapy_summary.pdf. Accessed May 20, 2014.
EMB628205-01
US Food and Drug Administration. New safety measures announced for extended-release and long-acting opioids: ER/LA
opioid analgesic class labeling changes and postmarket requirements [letter to ER/LA opioid application holders]. September
10, 2013. http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM367697.pdf. Accessed May 20,
2014.
Utah Department of Health. Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain. Salt Lake City, UT: Utah
Dept of Health; 2009. http://www.dopl.utah.gov/licensing/forms/OpioidGuidlines.pdf. Accessed May 20, 2014.
Washington State Agency Medical Directors’ Group (AMDG).Interagency Guideline on Opioid Dosing for Chronic Non-cancer
Pain: An Educational Aid to Improve Care and Safety With Opioid Therapy. 2010 Update. Olympia, WA: Washington State
Agency Medical Directors Group; 2010. http://www.agencymeddirectors.wa.gov/Files/OpioidGdline.pdf. Accessed May 20,
2014.
Webster LR, Fine PG. Approaches to improve pain relief while minimizing opioid abuse liability. J Pain. 2010;11(7):602-611.
Weiner SG, Griggs CA, Mitchell PM, et al. Clinician impression versus prescription drug monitoring program criteria in the
assessment of drug-seeking behavior in the emergency department. Ann Emerg Med. 2013;62(4):281-289.
EMB628205-01